Betty Li

2.1k total citations
30 papers, 755 citations indexed

About

Betty Li is a scholar working on Immunology, Oncology and Hematology. According to data from OpenAlex, Betty Li has authored 30 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 16 papers in Oncology and 6 papers in Hematology. Recurrent topics in Betty Li's work include Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (10 papers). Betty Li is often cited by papers focused on Immune Cell Function and Interaction (13 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (10 papers). Betty Li collaborates with scholars based in United States, Netherlands and Portugal. Betty Li's co-authors include Karin Jooss, Melinda VanRoey, David M. Dorfman, Alan J. Korman, Changyu Wang, Tseng-hui Timothy Chen, Andrew D. Simmons, Rodney A. Prell, Scott J. Rodig and Bo Luan and has published in prestigious journals such as Blood, Gastroenterology and Cancer Research.

In The Last Decade

Betty Li

28 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Betty Li United States 13 512 447 186 72 66 30 755
Arcadi Cipponi Italy 10 495 1.0× 476 1.1× 156 0.8× 59 0.8× 44 0.7× 14 783
Chiara Casati Italy 13 579 1.1× 563 1.3× 274 1.5× 147 2.0× 32 0.5× 13 911
Melanie Märklin Germany 13 364 0.7× 295 0.7× 229 1.2× 37 0.5× 54 0.8× 49 686
Vadim Deyev United States 13 458 0.9× 238 0.5× 152 0.8× 73 1.0× 58 0.9× 17 759
Weiqing Jing United States 15 479 0.9× 452 1.0× 225 1.2× 63 0.9× 38 0.6× 29 825
Seiji Nagano Japan 12 232 0.5× 335 0.7× 277 1.5× 49 0.7× 32 0.5× 25 607
Mobin Karimi United States 11 524 1.0× 414 0.9× 291 1.6× 71 1.0× 64 1.0× 32 927
Andreas Draube Germany 14 501 1.0× 413 0.9× 215 1.2× 33 0.5× 94 1.4× 30 807
Jeffrey J. Pu United States 14 269 0.5× 241 0.5× 214 1.2× 54 0.8× 115 1.7× 50 686
Mingqing Zhu China 11 380 0.7× 439 1.0× 246 1.3× 101 1.4× 66 1.0× 53 809

Countries citing papers authored by Betty Li

Since Specialization
Citations

This map shows the geographic impact of Betty Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Betty Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Betty Li more than expected).

Fields of papers citing papers by Betty Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Betty Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Betty Li. The network helps show where Betty Li may publish in the future.

Co-authorship network of co-authors of Betty Li

This figure shows the co-authorship network connecting the top 25 collaborators of Betty Li. A scholar is included among the top collaborators of Betty Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Betty Li. Betty Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Peirong, Suzanne Crawley, Betty Li, et al.. (2025). The scavenger receptor MARCO is a ligand for the immune inhibitory receptor LAIR-1 and regulates its function in cis. Science Signaling. 18(916). eado2768–eado2768.
2.
Nguyen, Alan A., et al.. (2023). Clinical utility of measuring CD4+ T follicular cells in patients with immune dysregulation. Journal of Autoimmunity. 140. 103088–103088. 5 indexed citations
3.
Keegan, Alissa, Ryan J. Schmidt, Daniel J. DeAngelo, et al.. (2018). Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease. Journal of Clinical Pathology. 71(7). 653–658. 6 indexed citations
4.
Li, Betty, Johan Nordenstam, Anders Mellgren, et al.. (2017). New Indications for Teduglutide in Temporary Intestinal Failure Patients. Gastroenterology. 152(5). S813–S813. 1 indexed citations
5.
Dorfman, David M., et al.. (2016). FLOCK cluster analysis of plasma cell flow cytometry data predicts bone marrow involvement by plasma cell neoplasia. Leukemia Research. 48. 40–45. 7 indexed citations
6.
Weinberg, Olga K., Robert P. Hasserjian, Betty Li, & Olga Pozdnyakova. (2016). Assessment of myeloid and monocytic dysplasia by flow cytometry in de novo AML helps define an AML with myelodysplasia-related changes category. Journal of Clinical Pathology. 70(2). 109–115. 4 indexed citations
7.
Dorfman, David M., et al.. (2015). FLOCK Cluster Analysis of Mast Cell Event Clustering by High-Sensitivity Flow Cytometry Predicts Systemic Mastocytosis. American Journal of Clinical Pathology. 144(5). 764–770. 4 indexed citations
8.
Pozdnyakova, Olga, et al.. (2014). High-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis. Leukemia & lymphoma. 56(6). 1735–1741. 5 indexed citations
9.
10.
Marsee, Derek K., Betty Li, & David M. Dorfman. (2010). Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma Cells. American Journal of Clinical Pathology. 133(5). 694–699. 12 indexed citations
11.
Li, Betty, Melinda VanRoey, Changyu Wang, et al.. (2009). Anti–Programmed Death-1 Synergizes with Granulocyte Macrophage Colony-Stimulating Factor–Secreting Tumor Cell Immunotherapy Providing Therapeutic Benefit to Mice with Established Tumors. Clinical Cancer Research. 15(5). 1623–1634. 153 indexed citations
12.
Li, Betty, Andrew D. Simmons, Carol Y. Lin, et al.. (2009). Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies. Clinical Immunology. 133(2). 184–197. 16 indexed citations
13.
Li, Betty, et al.. (2008). Enhancement of the anti-tumor efficacy of a GM-CSF–secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside. Experimental Hematology. 36(3). 319–328. 15 indexed citations
14.
Li, Betty, Jianmin Lin, Melinda VanRoey, Maria Jure–Kunkel, & Karin Jooss. (2007). Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb. Clinical Immunology. 125(1). 76–87. 49 indexed citations
15.
Li, Betty, Melinda VanRoey, & Karin Jooss. (2007). Recombinant IL-7 enhances the potency of GM-CSF-secreting tumor cell immunotherapy. Clinical Immunology. 123(2). 155–165. 33 indexed citations
16.
Simmons, Andrew D., Betty Li, Carol Y. Lin, et al.. (2007). GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action. Cancer Immunology Immunotherapy. 56(10). 1653–1665. 36 indexed citations
17.
Li, Betty, Alshad S. Lalani, Thomas Harding, et al.. (2005). Blockade of Vascular Endothelial Growth Factor (VEGF) Enhances the Therapeutic Efficacy of GM-CSF Secreting Tumor Cell Vaccines. Journal of Immunotherapy. 28(6). 615–616. 1 indexed citations
18.
Prell, Rodney A., et al.. (2005). Administration of IFN-α Enhances the Efficacy of a Granulocyte Macrophage Colony Stimulating Factor–Secreting Tumor Cell Vaccine. Cancer Research. 65(6). 2449–2456. 19 indexed citations
19.
Rodig, Scott J., Ali Shahsafaei, Betty Li, Charles R. Mackay, & David M. Dorfman. (2005). BAFF-R, the major B cell–activating factor receptor, is expressed on most mature B cells and B-cell lymphoproliferative disorders. Human Pathology. 36(10). 1113–1119. 72 indexed citations
20.
Rodig, Scott J., Aliakbar Shahsafaei, Betty Li, & David M. Dorfman. (2004). The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders. Human Pathology. 36(1). 51–57. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arcadi Cipponi Breakdown of academic impact, for papers by Chiara Casati Breakdown of academic impact, for papers by Melanie Märklin Breakdown of academic impact, for papers by Vadim Deyev Breakdown of academic impact, for papers by Weiqing Jing Breakdown of academic impact, for papers by Seiji Nagano Breakdown of academic impact, for papers by Mobin Karimi Breakdown of academic impact, for papers by Andreas Draube Breakdown of academic impact, for papers by Jeffrey J. Pu Breakdown of academic impact, for papers by Mingqing Zhu
Rankless by CCL
2026